Last updated on January 2020

A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors


Brief description of study

This study will evaluate the safety, efficacy, and pharmacokinetics of atezolizumab in combination with bevacizumab, bevacizumab + oxaliplatin, leucovorin and 5-fluorouracil (5-FU) (FOLFOX), vanucizumab, nab-paclitaxel + gemcitabine, FOLFOX, or 5-FU + cisplatin, in participants with solid tumors.

Clinical Study Identifier: NCT02715531

Find a site near you

Start Over

Helen Diller Fam Comp Can Ctr

San Francisco, CA United States
  Connect »

Yale School of Medicine

New Haven, CT United States
  Connect »

Mayo Clinic

Rochester, MN United States
  Connect »

Duke Cancer Institute

Durham, NC United States
  Connect »

Sarah Cannon Research Inst.

Nashville, TN United States
  Connect »

Severance Hospital

Seoul, Korea, Republic of
  Connect »

Medical College of Wisconsin

Milwaukee, WI United States
  Connect »

Austin Hospital

Heidelberg, Australia
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »